A Flexible Bayesian Approach for Modeling Monotonic Dose–Response Relationships in Drug Development Trials

References

• Aitkin, M. (1991). Posterior Bayes factors. Journal of the Royal Statistical Society Series B (Statistical Methodology) 53:111–142.
   Web of Science ®Google Scholar
• Alvarez, E. E., Dey, D. K. (2009). Bayesian isotonic changepoint analysis. Annals of the Institute of Statistical Mathematics 61:355–370.
   Web of Science ®Google Scholar
• Berger, J., Pericchi, L. (1996). The intrinsic Bayes factor for model selection and prediction. Journal of the American Statistical Association 91:109–122.
   Web of Science ®Google Scholar
• Bornkamp, B., Bretz, F., Dmitrienko, A., Enas, G., Gaydos, B., Hsu, C.-H., König, F., Krams, M., Liu, Q., Neuenschwander, B. et al. (2007). Innovative approaches for designing and analyzing adaptive dose-ranging trials. Journal of Biopharmaceutical Statistics 17:965–995.
   PubMed Web of Science ®Google Scholar
• Bretz, F., Pinheiro, J., Branson, M. (2005). Combining multiple comparisons and modeling techniques in dose-response studies. Biometrics 61:738–748.
   PubMed Web of Science ®Google Scholar
• Carlin, B., Chib, S. (1995). Bayesian model choice via Markov Chain monte Carlo methods. Journal of the Royal Statistical Society Series B (Statistical Methodology) 57:473–484.
   Web of Science ®Google Scholar
• Celeux, G., Forbes, F., Robert, C., Titterington, D. (2006). Deviance information criteria for missing data models. Bayesian Analysis 1:651–674.
   Web of Science ®Google Scholar
• Dellaportas, P., Forster, J., Ntzoufras, I. (2002) On Bayesian model and variable selection using MCMC. Statistics and Computing 12:27–36.
   Web of Science ®Google Scholar
• European Medicines Agency Evaluation of Medicines for Human Use (2008). Assessment report for Vimpat. Doc.Ref.: EMEA/460925/2008.
   Google Scholar
• Gelman, A., Carlin, J., Stern, H., Rubin, D. (2004). Bayesian Data Analysis (2nd edition). New York: Chapman & Hall.
   Google Scholar
• Green, P. (1995). Reversible jump Markov chain Monte Carlo computation and Bayesian model determination. Biometrika 82:711–732.
   Web of Science ®Google Scholar
• Halford, J., Lapointe, M. (2009). Clinical perspectives on lacosamide. Epilepsy Curr. 9:1–9.
   PubMed Web of Science ®Google Scholar
• Hoeting, J., Madigan, D., Raftery, A., Volinsky, C. (1999). Bayesian model averaging: A tutorial. Statistical Science 14:382–401.
   Web of Science ®Google Scholar
• Link, W., Barker, R. (2006) Model weights and the foundations of multimodel inference. Ecology 87:2626–2635.
   PubMed Web of Science ®Google Scholar
• Lunn, D., Thomas, A., Best, N., Spiegelhalter, D. (2000). WinBUGS-A Bayesian modelling framework: Concepts, structure, and extensibility. Statistics and Computing 10:325–337.
   Web of Science ®Google Scholar
• Neelon, B., Dunson, D. B. (2004). Bayesian isotonic regression and trend analysis. Biometrics 60:398–406.
   PubMed Web of Science ®Google Scholar
• O’Hagan, A. (1995). Fractional Bayes factors for model comparison. Journal of the Royal Statistical Society Series B (Statistical Methodology) 57:99–138.
   Web of Science ®Google Scholar
• Pinheiro, J., Bornkamp, B., Bretz, F. (2006). Design and analysis of dose-finding studies combining multiple comparisons and modeling procedures. Journal of Biopharmaceutical Statistics 16:639–656.
   PubMed Web of Science ®Google Scholar
• Ramsey, F. L. (1972). A Bayesian approach to bioassay. Biometrics 28: 841–858.
   PubMed Web of Science ®Google Scholar
• Sisson, S. (2005). Transdimensional Markov Chains: A decade of progress and future perspectives. Journal of the American Statistical Association 100:1077–1090.
   Web of Science ®Google Scholar
• Smith, M., Jones, I., Morris, M., Grieve, A., Tan, K. (2006). Implementation of a Bayesian adaptive design in a proof of concept study. Pharmaceutical Statistics 5:39.
   PubMed Web of Science ®Google Scholar
• Spiegelhalter, D., Abrams, K., Myles, J. (2004). Bayesian Approaches to Clinical Trials and Health-Care Evaluation. Chichester: Wiley.
   Google Scholar
• Spiegelhalter, D., Best, N., Carlin, B., van der Linde, A. (2002) Bayesian measures of model complexity and fit. Journal of the Royal Statistical Society Series B (Statistical Methodology) 64:583–639.
   Web of Science ®Google Scholar
• Whitehead, J., Thygesen, H., Whitehead, A. (2010) A Bayesian dose-finding procedure for phase I clinical trials based only on the assumption of monotonicity. Statistics in Medicine 29:1808–1824.
   PubMed Web of Science ®Google Scholar